Peer-reviewed article examines EBPCC effectiveness across generations of older cancer patients and proposes holistic care model for future needs. Read More
Peer-reviewed study on plain language summaries supporting patient involvement in HTA: NICE and CEEU pilots, findings, and 8 recommendations. Read More
QUALITOP consortium’s final conference report documents 4 years of EU research on quality of life in cancer immunotherapy, including Smart Digital Platform development. Read More
QUALITOP consortium’s final conference report documents 4 years of EU research on quality of life in cancer immunotherapy, including Smart Digital Platform development. Read More
39 stakeholders call on EU HTA Coordination Group to adopt fit-for-purpose JCA methodology for ATMPs, recognising single-arm trials and real-world evidence. Read More
CPE supports the ASCERTAIN project survey on Cost-Effectiveness Thresholds in healthcare. Share your views to help shape equitable HTA tools across Europe. Read More
This White Paper, co-developed by Cancer Patients Europe and partner patient organisations across five countries, addresses the policy and disease management gaps that emerged… Read More
CPE and partners call on EU institutions to embed Treatment Optimisation and Pragmatic Clinical Trials in pharmaceutical law to improve real-world cancer care. Read More
CPE’s ESMO 2023 poster reveals only 1 in 5 eligible breast cancer patients were told about genomic testing. See the European survey data. Read More
CPE’s myC White Paper reveals 78% of eligible breast cancer patients were never told about genomic testing. Read the Call to Action for Europe. Read More